Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study

被引：0
|
作者：
J. C. Bertoglio
M. Baumgartner
R. Palma
E. Ciampi
C. Carcamo
D. D. Cáceres
G. Acosta-Jamett
J. L. Hancke
R. A. Burgos
机构：
[1] Instituto de Medicina,Departamento de Neurología
[2] Universidad Austral de Chile,undefined
[3] Hospital Regional de Valdivia,undefined
[4] Centro de Esclerosis Multiple,undefined
[5] Facultad de Medicina,undefined
[6] Pontificia Universidad Católica,undefined
[7] Programa de Salud Ambiental,undefined
[8] Escuela de Salud Pública,undefined
[9] Facultad de Medicina,undefined
[10] Universidad de Chile,undefined
[11] Instituto de Medicina Preventiva Veterinaria y Programa de Investigación Aplicada en Fauna Silvestre,undefined
[12] Facultad de Ciencias Veterinarias,undefined
[13] Universidad Austral de Chile,undefined
[14] Instituto de Farmacología,undefined
[15] Facultad de Ciencias Veterinarias,undefined
[16] Universidad Austral de Chile,undefined
来源：
BMC Neurology | / 16卷
关键词：
Fatigue; Multiple sclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
    Bertoglio, J. C.
    Baumgartner, M.
    Palma, R.
    Ciampi, E.
    Carcamo, C.
    Caceres, D. D.
    Acosta-Jamett, G.
    Hancke, J. L.
    Burgos, R. A.
    BMC NEUROLOGY, 2016, 16
  • [2] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [3] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [4] Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study
    Etemadifar, Masoud
    Sayahi, Farnaz
    Abtahi, Seyed-Hossein
    Shemshaki, Hamidreza
    Dorooshi, Gholam-Ali
    Goodarzi, Mohammad
    Akbari, Mojtaba
    Fereidan-Esfahani, Mahboobeh
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (07) : 480 - 486
  • [5] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Foshati, Sahar
    Poursadeghfard, Maryam
    Heidari, Zahra
    Amani, Reza
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [6] Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
    Metz, L. M.
    Li, D.
    Traboulsee, A.
    Myles, M. L.
    Duquette, P.
    Godin, J.
    Constantin, M.
    Yong, V. W.
    MULTIPLE SCLEROSIS, 2009, 15 (10): : 1183 - 1194
  • [7] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Sahar Foshati
    Maryam Poursadeghfard
    Zahra Heidari
    Reza Amani
    BMC Complementary Medicine and Therapies, 23
  • [8] High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial
    Ashtari, Fereshteh
    Toghianifar, Nafiseh
    Zarkesh-Esfahani, Sayyed Hamid
    Mansourian, Marjan
    NEUROLOGICAL RESEARCH, 2016, 38 (10) : 888 - 892
  • [9] Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial
    Keramatzadeh, Sara
    Hosseini, Seyed Ahmad
    Majdinasab, Nastaran
    Cheraghian, Bahman
    Zilaee, Marzie
    NUTRITIONAL NEUROSCIENCE, 2024,
  • [10] Placebo-controlled trials in relapsing-remitting multiple sclerosis: are they still needed?
    Waschbisch, Anne
    Derfuss, Tobias
    FUTURE NEUROLOGY, 2012, 7 (01) : 37 - 44
12345